Lynch & Associates Medtronic PLC Transaction History
Lynch & Associates
- $455 Million
- Q1 2025
A detailed history of Lynch & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Lynch & Associates holds 9,714 shares of MDT stock, worth $839,678. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,714
Previous 9,259
4.91%
Holding current value
$839,678
Previous $739,000
18.0%
% of portfolio
0.19%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding MDT
# of Institutions
2,440Shares Held
1.05BCall Options Held
10.3MPut Options Held
9.61M-
Vanguard Group Inc Valley Forge, PA125MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.67 Billion0.2% of portfolio
-
State Street Corp Boston, MA60MShares$5.19 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.6MShares$3.59 Billion0.85% of portfolio
-
Jpmorgan Chase & CO New York, NY37.6MShares$3.25 Billion0.27% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $115B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...